Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

Boehringer Ingelheim Investigational Site, Toulouse

Boehringer Ingelheim Investigational Site, Bordeaux

Boehringer Ingelheim Investigational Site, Dole

CH Toul, Toul

Boehringer Ingelheim Investigational Site, Lunéville

Boehringer Ingelheim Investigational Site, Maxéville

Boehringer Ingelheim Investigational Site, Vandœuvre-lès-Nancy

Boehringer Ingelheim Investigational Site, Metz

Hôpital Notre Dame de Bon Secours, Metz

Boehringer Ingelheim Investigational Site, Montigny-lès-Metz

CH Laennec, Creil

Hôpital Gabriel Montpied, Clermont-Ferrand

Boehringer Ingelheim Investigational Site, Cambo-les-Bains

Centre Médical Annie Enia, Cambo-les-Bains

Boehringer Ingelheim Investigational Site, Colmar

Boehringer Ingelheim Investigational Site, Mulhouse

MAPI CRO, Lyon

Boehringer Ingelheim Investigational Site, Châlons Sur Saône

Boehringer Ingelheim Investigational Site, Aix-les-Bains

Hôpital Pitié Salpétrière, Paris

Hôpital Cochin, Paris

Boehringer Ingelheim Investigational Site, Poitiers

Hôpital Saint Charles, Saint-Dié

Centre Hospitalier, Longjumeau

Hôpital Privé Antony, Antony

Groupe Hospitalier Sud Réunion, Saint-Pierre

Boehringer Ingelheim Investigational Site, Saint-Quentin